FRANKFURT, Jan 12 (Reuters) - German drugs and pesticides
maker Bayer, which will need regulatory approval for
its $66 billion deal to buy U.S. seeds giant Monsanto,
said company chief executives had a productive meeting with U.S.
president-elect Donald Trump.
Read more
No comments:
Post a Comment